このエントリーをはてなブックマークに追加
ID 53538
タイトル(別表記)
An investigator initiated phase II clinical trial of tamibarotene (AM80G) for chronic graft-versus-host disease
フルテキストURL
Thumnail 127_133.pdf 1.63 MB
著者
西森 久和 岡山大学病院
前田 嘉信 岡山大学病院
キーワード
臨床研究中核病院
慢性GVHD
タミバロテン
同種造血幹細胞移植
Th17
備考
特集(Feature Articles)
出版物タイトル
岡山医学会雑誌
発行日
2015-08-03
127巻
2号
出版者
岡山医学会
出版者(別表記)
Okayama Medical Association
開始ページ
133
終了ページ
137
ISSN
0030-1558
NCID
AN00032489
資料タイプ
学術雑誌論文
関連URL
isVersionOf https://doi.org/10.4044/joma.127.133
OAI-PMH Set
岡山大学
言語
Japanese
著作権者
Copyright (c) 2015 岡山医学会
論文のバージョン
publisher
査読
有り
DOI
NAID
Sort Key
10
Eprints Journal Name
joma
参考文献
1) Teshima T, Maeda Y, Ozaki K : Regulatory T cells and IL-17-producing cells in graft-versus-host disease. Immunotherapy (2011) 3, 833-852.
2) Nishimori H, Maeda Y, Teshima T, Sugiyama H, Kobayashi K, Yamasuji Y, Kadohisa S, Uryu H, Takeuchi K, Tanaka T, Yoshino T, Iwakura Y, et al. : Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17. Blood (2012) 119, 285-295.
3) Nishimori H, Maeda Y, Tanimoto M : Chronic graft-versus-host disease : disease biology and novel therapeutic strategies. Acta Med Okayama (2013) 67, 1-8.
4) Ferrara JL, Antin JH : The pathophysiology of graft-vs-host disease ; in Thomas'Hematopoietic Cell Transplantation Malden, Blume KG, Forman SJ, Appelbaum FR (eds), Blackwell Science, MA, USA (2004) pp353-368.
5) Martin PJ, Inamoto Y, Carpenter PA, Lee SJ, Flowers ME : Treatment of chronic graft-versus-host disease : Past, present and future. Korean J Hematol (2011) 46, 153-163.
6) Koreth J, Matsuoka K, Kim HT, McDonough SM, Bindra B, Alyea EP 3rd, Armand P, Cutler C, Ho VT, Treister NS, Bienfang DC, Prasad S, et al. : Interleukin-2 and regulatory T cells in graft-versus-host disease. N Engl J Med (2011) 365、2055-2066.
7) Hashimoto Y, Shudo K : Retinoids and their nuclear receptors. Cell Biol Rev (1991) 25, 209-235.
8) Hashimoto Y : Retinobenzoic acids and nuclear retinoic acid receptors. Cell Struct Funct (1991) 16, 113-123.
9) Hashimoto Y, Kagechika H, Kawachi E, Fukasawa H, Saito G, Shudo K : Correlation of differentiation-inducing activity of retinoids on human leukemia cell lines HL-60 and NB4. J Cancer Res Clin Oncol (1995) 121, 696-698.
10) Kagechika H, Kawachi E, Hashimoto Y, Himi T, Shudo K : Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity. J Med Chem (1988) 31, 2182-2192.
11) Shinagawa K, Yanada M, Sakura T, Ueda Y, Sawa M, Miyatake J, Dobashi N, Kojima M, Hatta Y, Emi N, Tamaki S, Gomyo H, et al. : Tamibarotene as maintenance therapy for acute promyelocytic leukemia : results from a randomized controlled trial. J Clin Oncol (2014) 32, 3729-3735.
12) Tobita T, Takeshita A, Kitamura K, Ohnishi K, Yanagi M, Hiraoka A, Karasuno T, Takeuchi M, Miyawaki S, Ueda R, Naoe T, Ohno R : Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid. Blood (1997) 90, 967-973.
13) Nagai H, Matsuura S, Bouda K, Takaoka Y, Wang T, Niwa S, Shudo K : Effect of Am-80, a synthetic derivative of retinoid, on experimental arthritis in mice. Pharmacology (1999) 58, 101-112.
14) Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M, Cheroutre H : Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science (2007) 317, 256-260.
15) Okamoto S, Fujiwara H, Nishimori H, Matsuoka K, Fujii N, Kondo E, Tanaka T, Yoshimura A, Tanimoto M, Maeda Y : Anti-IL-12/23 p40 antibody attenuates experimental chronic graft-versus-host disease via suppression of IFN-gamma/IL-17-producing cells. J Immunol (2015) 194, 1357-1363.
16) Inamoto Y, Storer BE, Lee SJ, Carpenter PA, Sandmaier BM, Flowers ME, Martin PJ : Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease. Blood (2013) 121, 2340-2346.